Sequential Therapy for Remission Induction in Severe Antineutrophil Cytoplasmic Autoantibody-Associated Glomerulonephritis.
Kant, Sam
Sequential Therapy for Remission Induction in Severe Antineutrophil Cytoplasmic Autoantibody-Associated Glomerulonephritis. [electronic resource] - American journal of nephrology 2019 - 386-391 p. digital
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
1421-9670
10.1159/000503318 doi
Adult
Aged
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis--diagnosis
Cyclophosphamide--administration & dosage
Dose-Response Relationship, Drug
Drug Administration Schedule
Drug Therapy, Combination--adverse effects
Female
Glomerular Filtration Rate--drug effects
Glomerulonephritis--diagnosis
Glucocorticoids--administration & dosage
Humans
Immunosuppressive Agents--administration & dosage
Male
Middle Aged
Remission Induction--methods
Rituximab--administration & dosage
Severity of Illness Index
Treatment Outcome
Sequential Therapy for Remission Induction in Severe Antineutrophil Cytoplasmic Autoantibody-Associated Glomerulonephritis. [electronic resource] - American journal of nephrology 2019 - 386-391 p. digital
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
1421-9670
10.1159/000503318 doi
Adult
Aged
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis--diagnosis
Cyclophosphamide--administration & dosage
Dose-Response Relationship, Drug
Drug Administration Schedule
Drug Therapy, Combination--adverse effects
Female
Glomerular Filtration Rate--drug effects
Glomerulonephritis--diagnosis
Glucocorticoids--administration & dosage
Humans
Immunosuppressive Agents--administration & dosage
Male
Middle Aged
Remission Induction--methods
Rituximab--administration & dosage
Severity of Illness Index
Treatment Outcome